Use In Specific Populations Pregnancy Risk Summary Available data from cases reported in the published literature and postmarketing surveillance with CYANOKIT use in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage, or adverse maternal and fetal outcomes
S., Veneroso, C., Reiter, R
Jbra Assist Reprod 22:6166 Ala M, Ramos S, Mateos R, Bravo L, Goya L (2005) Response of the antioxidant defense system to tert-butyl hydroperoxide and hydrogen peroxide in a human hepatoma cell line (HepG2)
The challenge is that awareness has grown much faster than the evidence, so its become difficult for people to separate genuine science from clever marketing. For people frustrated by persistent tendon pain or recurring injuries, that marketing can be particularly persuasive